- Home
- SABS vs SEED Comparison
SABS vs SEED Comparison
Compare SABS & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- SEED
- Stock Information
- Founded
- SABS 2014
- SEED 1997
- Country
- SABS United States
- SEED China
- Employees
- SABS N/A
- SEED N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- SEED Farming/Seeds/Milling
- Sector
- SABS Health Care
- SEED Consumer Staples
- Exchange
- SABS Nasdaq
- SEED Nasdaq
- Market Cap
- SABS 19.0M
- SEED 16.1M
- IPO Year
- SABS N/A
- SEED N/A
- Fundamental
- Price
- SABS $1.82
- SEED $2.02
- Analyst Decision
- SABS Strong Buy
- SEED
- Analyst Count
- SABS 5
- SEED 0
- Target Price
- SABS $12.40
- SEED N/A
- AVG Volume (30 Days)
- SABS 246.2K
- SEED 128.0K
- Earning Date
- SABS 03-28-2025
- SEED 02-10-2025
- Dividend Yield
- SABS N/A
- SEED N/A
- EPS Growth
- SABS N/A
- SEED N/A
- EPS
- SABS N/A
- SEED 0.46
- Revenue
- SABS $1,512,723.00
- SEED $16,163,803.00
- Revenue This Year
- SABS N/A
- SEED N/A
- Revenue Next Year
- SABS N/A
- SEED N/A
- P/E Ratio
- SABS N/A
- SEED $4.43
- Revenue Growth
- SABS N/A
- SEED 21.51
- 52 Week Low
- SABS $1.60
- SEED $1.64
- 52 Week High
- SABS $6.30
- SEED $6.38
- Technical
- Relative Strength Index (RSI)
- SABS 36.28
- SEED 42.55
- Support Level
- SABS $2.00
- SEED $2.08
- Resistance Level
- SABS $2.15
- SEED $2.21
- Average True Range (ATR)
- SABS 0.20
- SEED 0.21
- MACD
- SABS 0.03
- SEED -0.03
- Stochastic Oscillator
- SABS 30.99
- SEED 12.82
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company. In crop seed biotechnologies, the company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.